ADAM12 and nonpapillary renal cell carcinoma: Pathway enrichment analysis indicated that ADAM12 was involved in the development of ccRCC through immune-related pathways, and further investigation revealed that ADAM12 expression was associated with immune cell infiltration into tumors.